Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

BACKGROUND: Efficacy of oral pre-exposure prophylaxis (PrEP) in prevention of HIV acquisition has been evaluated using a daily regimen. However, adherence to long term daily medication is rarely perfect. Intermittent regimen may be a feasible alternative. Preclinical studies have demonstrated effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kibengo, Freddie M., Ruzagira, Eugene, Katende, David, Bwanika, Agnes N., Bahemuka, Ubaldo, Haberer, Jessica E., Bangsberg, David R., Barin, Burc, Rooney, James F., Mark, David, Chetty, Paramesh, Fast, Patricia, Kamali, Anatoli, Priddy, Frances H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784443/
https://www.ncbi.nlm.nih.gov/pubmed/24086333
http://dx.doi.org/10.1371/journal.pone.0074314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784443/
https://www.ncbi.nlm.nih.gov/pubmed/24086333
http://dx.doi.org/10.1371/journal.pone.0074314

Ejemplares similares